Efficacy [qlco]    
Safety [hcpp]    
FOLFOX-4 Regimen [topp]    
chinese [lang]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Subgroup Analysis [resa]    
Study [mnob]    
Study [mnob]    
Assessed [acty]    
Efficacy [qlco]    
FOLFOX-4 Regimen [topp]    
Compared [acty]    
Alone [qnco]    
Survival [acty]    
Progression-Free Survival [qnco]    
Safety [hcpp]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Present [qnco]    
Study [mnob]    
chinese [lang]    
Patients [podg]    
Methods [inpr]    
Multicentric [spco]    
OPEN LABEL [resa]    
Randomized [resa]    
Phase III Study [resa]    
Patients [podg]    
Patients [podg]    
Randomized [resa]    
Receive [qlco]    
Either [fndg]    
Disease Progression [patf]    
toxicity [qlco]    
DEATH [orgf]    
surgical resection [topp]    
baseline [bodm]    
Characteristics [qlco]    
chinese [lang]    
Patients [podg]    
Study [mnob]    
treatment [ftcn]    
Groups [idcn]    
Comparison [acty]    
Whole [qnco]    
Median [spco]    
Survival [acty]    
Timepoint [tmco]    
treatment [ftcn]    
Hazard Ratio [qnco]    
End [spco]    
Median [spco]    
Survival [acty]    
5 - 9 [fndg]    
Hazard Ratio [qnco]    
Median [spco]    
Progression-Free Survival [qnco]    
2 Months [tmco]    
1-7 [gngm]    
Groups [idcn]    
Hazard Ratio [qnco]    
Response Rate [tmco]    
disease rate [qnco]    
control [qlco]    
Significantly high [qnco]    
Group [idcn]    
Group [idcn]    
Haematology NOS [bmod]    
toxicity [qlco]    
Frequently [tmco]    
Reported [inpr]    
Group [idcn]    
chinese [lang]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Study [mnob]    
Improved [qlco]    
Response Rate [tmco]    
Prolonged [tmco]    
Survival [acty]    
Compared [acty]    
Systemic Chemotherapy [topp]    
Based [ftcn]    
regimens [inpr]    
Play [dora]    
Important [qlco]    
treatment [ftcn]    
chinese [lang]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
